Originally published In Press as doi:10.1074/jbc.M208580200 on October 24, 2002
J. Biol. Chem., Vol. 277, Issue 52, 50893-50898, December 27, 2002
Functional Analysis of Cdc42 Residues Required for Guanine
Nucleotide Exchange*
Kent L.
Rossman
§¶,
David K.
Worthylake
¶,
Jason
T.
Snyder
,
Li
Cheng
,
Ian P.
Whitehead
, and
John
Sondek
§**
From the
Department of Pharmacology,
** Department of Biochemistry and Biophysics and
§ Lineberger Comprehensive Cancer Center, University of
North Carolina, Chapel Hill, North Carolina 27599 and the
Department of Microbiology and Molecular Genetics, University of
Medicine and Dentistry of New Jersey, New Jersey Medical School,
Newark, New Jersey 07103
Received for publication, August 21, 2002, and in revised form, October 22, 2002
 |
ABSTRACT |
Guanine nucleotide exchange factors (GEFs)
directly engage small GTPases to facilitate the exchange of bound GDP
for GTP, leading to GTPase activation. Several recent crystal
structures of GEFs in complex with Rho family GTPases highlight the
conserved interactions and conformational alterations necessary for
catalyzing exchange. In the present study, functional roles were
defined for specific residues within Cdc42 implicated by the crystal
structures as important for physiological exchange of guanine
nucleotides within Rho GTPases. In particular, this study highlights
the paramount importance of the phosphate-binding loop and interactions
with the magnesium co-factor as critical for proper regulation of
RhoGEF-catalyzed exchange. Other conformational alterations of the
GTPases affecting interactions with the sugar and base of guanine
nucleotides are also important but are secondary. Of particular note,
substitution of alanine for cysteine at position 18 of Cdc42 leads to a
fast cycling phenotype for Cdc42 with heightened affinity for RhoGEFs and produces a dominant negative form of Cdc42 capable of inhibiting RhoGEFs both in vitro and in vivo.
 |
INTRODUCTION |
Similar to other members of the Ras superfamily, Rho
family GTPases are biologically active when bound to GTP and are
deactivated upon hydrolysis of GTP to GDP, a reaction typically
accelerated by Rho GTPase-activating proteins
(GAPs).1 Guanine nucleotide
exchange factors (GEFs) rapidly convert GTPases to their biologically
active states by catalyzing the exchange of GDP for GTP. Currently, Dbl
(diffuse B-cell lymphoma) family members constitute the largest group of GEFs for Rho GTPases (1-3) and
are easily recognized by the invariant placement of a pleckstrin homology (PH) domain immediately carboxyl-terminal to a Dbl homology (DH) domain. Isolated DH domains typically possess significant exchange
potential that can be enhanced by the adjacent PH domain (4, 5). The
invariant linkage of DH and PH domains hints at a conserved function
that is currently poorly understood.
As proposed for other GEFs, the reaction scheme for Dbl-stimulated
exchange includes the formation of a low affinity
GEF·GTPase·GDP·Mg2+ quaternary complex that rapidly
converts to a high affinity GEF·GTPase binary complex concomitant
with expulsion of GDP and Mg2+ (6). The reaction proceeds
with the binding of GTP·Mg2+ to form an unstable
quaternary complex of GEF·GTPase·GTP·Mg2+, followed
by dissociation of the GEF from the GTP-bound GTPase.
We have recently determined crystal structures of several unique DH/PH
fragments in complex with their cognate Rho family GTPases (5, 7, 8),
and the structures indicate a conserved mechanism of exchange. For
example, Rho GTPases possess two "switch" regions that are
conformationally sensitive to the state of bound nucleotide, and these
switch regions occupy similar conformations in all current structures
of Rho GTPases bound to GEFs. Certain conformational features of DH
domain-bound Rho GTPases are also present in other GEF·GTPase
structures, such as Sos1 (Cdc25 domain)·Ras (9), RCC1·Ran (10), and
SopE·Cdc42 (11), and are indicative of conserved aspects of the
catalyzed exchange mechanism utilized by various GEF families.
In order to more thoroughly understand the relative contributions of
key structural features in facilitating guanine nucleotide exchange by
RhoGEFs, Cdc42 and the Dbl family member Dbs (for Dbl's
big sister) were mutated at critical sites, and
the functional consequences were determined. This analysis indicates
that mutations that affect Mg2+ binding are critical for
efficient GEF-catalyzed exchange. Specifically, the methyl group of
Ala59 within Cdc42 or its equivalent in Rac1 and RhoA
normally impinges upon the Mg2+ binding site within the
GEF·GTPase complexes. Consequently, substitution of alanine 59 to
glycine in Cdc42 severely cripples GEF binding and exchange. Similarly,
interactions that support the steric overlap of Ala59 and
the Mg2+-binding site also appear critical for nucleotide
exchange. Mutations that affect interactions with the sugar or base of
guanine nucleotides also have significant effects on exchange, but
these effects are secondary to disruption of Mg2+ binding.
One mutation (C18A) in Cdc42, designed to disrupt a hydrogen bond with
the
-phosphate of guanine nucleotides, is particularly notable,
since it confers a dominant negative phenotype upon Cdc42. Cdc42(C18A)
is impaired in nucleotide binding and consequently binds Dbs with
higher affinity than wild-type Cdc42. In vivo, Cdc42(C18A)
exhibits a dominant-negative phenotype, presumably by sequestering
exchange factors in nucleotide-depleted complexes analogous to other,
better characterized variants of Rho GTPases (i.e. Cdc42(T17N)).
 |
EXPERIMENTAL PROCEDURES |
Guanine Nucleotide Exchange Assays--
A carboxyl-terminal
His6-tagged, wild type DH/PH fragment (residues 623-967)
expression construct was derived from a cDNA library of
mouse brain as described previously (5). Mutations were introduced into
wild type Dbs DH/PH domain and Cdc42 using the QuikChange site-directed
mutagenesis kit (Stratagene) as per the manufacturer's instructions.
cDNA sequences of all protein expression constructs were verified
by automated sequencing. Dbs and Cdc42 proteins were expressed and
purified as described (5).
Fluorescence spectroscopic analysis of N-methylanthraniloyl
(mant)-GTP incorporation into bacterially purified Cdc42 and RhoA was
carried out using a PerkinElmer Life Sciences LS 50B spectrometer at
25 °C. Exchange assays containing 20 mM Tris, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1 mM dithiothreitol, and 100 µM mant-GTP
(Biomol) and a 1 or 2 µM concentration (as indicated) of
either Cdc42 or RhoA protein, were prepared and allowed to equilibrate
with continuous stirring. After equilibration, Dbs DH/PH domain was
added to 200 nM, and the rates of GTP loading
(kobs) for wild type and mutant Cdc42 proteins
were determined by monitoring the decrease in tryptophan fluorescence
(
ex = 295 nm,
em = 335 nm) in response to
binding mant-GTP (12-14). Because of their high intrinsic exchange
rate, Cdc42(C18A) and Cdc42(V33A) were added to equilibrated exchange reactions containing 200 nM Dbs.
To test the inhibition of Dbs-catalyzed exchange by Cdc42(C18A), 400 nM Cdc42(WT) preloaded with mant-GDP was stimulated
by 200 nM Dbs DH/PH in the presence of 2 µM
Cdc42(WT) or Cdc42(C18A), each bound to GDP. Reaction conditions were
similar to those described above except that 20 µM GDP
was used in place of 100 µM GTP and exchange was followed
by measuring the decrease in fluorescence resulting from mant-GDP
release from Cdc42 (
ex = 360 nm,
em = 440 nm).
The rates (kobs) of guanine nucleotide exchange
were determined by fitting the data as single exponential decays
utilizing GraphPad Prizm software. Data were normalized to wild type
curves to yield the percentage of GDP released. All experiments were performed at least in duplicate.
Surface Plasmon Resonance--
Cdc42 binding to Dbs was
monitored using surface plasmon resonance with a BIAcore 2000 instrument at 25 °C. His-tagged Dbs DH/PH domain was immobilized to
a nickel surface on a nitrilotriacetic acid sensor chip (BIAcore) as
described by the manufacturer. Cdc42 solutions (ranging in
concentration from 156 nM to 2.5 µM) were injected over the stable Dbs surface with or without 50 µM EDTA (used to chelate Mg2+ and remove
nucleotide) at 25 µl/min for 25 s and allowed to dissociate for
60 s in phosphate-buffered saline. Raw data were normalized to the
signal achieved due to binding a surface lacking Dbs. Normalized sensorgrams were aligned, and the steady state binding signal from each
curve was fit to a single binding isotherm. The resulting dissociation
constants are the mean of several sets of analyte concentrations.
Molecular Constructs--
The pAX142 mammalian expression
vector, pAX142-Cdc42(WT), and pAX-Cdc42(17N) have been described (15,
16). pAX142-Cdc42(C18A) was generated by PCR-based site-directed
mutagenesis and verified by automated sequencing. pAX142-Dbl-HA1
contains a cDNA that encodes a transforming derivative of Dbl fused
to an HA epitope tag (16). GST-PBD contains the Cdc42 binding domains
from the Cdc42/Rac1 effector protein Pak3 (17). The
NF-
B-luc and reporter construct utilized in the
transcriptional assays have been described previously (18). pCMVnlac
encodes the sequences for the
-galactosidase gene under the control
of the cytomegalovirus promoter (provided by J. Samulski).
Cell Culture, Transfection, and Transient Reporter Gene
Assays--
COS-7 cells were maintained in Dulbecco's modified
Eagle's medium (high glucose) supplemented with 10% fetal bovine
serum. Cells were transfected by DEAE-dextran (COS-7) as described
previously (17). Cells were allowed to recover for 30 h and
subsequently starved in Dulbecco's modified Eagle's medium
supplemented with 0.5% serum for 14 h before lysate preparation.
Analysis of luciferase expression with enhanced chemiluminescence
reagents and a Monolight 3010 luminometer (Analytical Luminescence, San
Diego, CA) was described previously (19, 20).
-Galactosidase
activity was determined using Lumi-Gal substrate (Lumigen, Southfield,
MI) according to the manufacturer's instructions. All assays were performed in triplicate.
Cdc42 Activation Assays in Vivo--
Affinity purification of
GTP-Cdc42 was performed as described previously (21). Briefly, the p21
binding domain of Pak3 was expressed as a GST fusion (GST-PBD)
in BL21(DE3) cells, immobilized to glutathione-coupled Sepharose 4B
beads (Amersham Biosciences) (17), and used to precipitate activated
GTP-bound Cdc42 from COS-7 cell lysates. Cells were washed in cold
phosphate-buffered saline prior to lysis in 50 mM Tris-HCl,
pH 7.4, 2 mM MgCl2, 100 mM NaCl,
10% glycerol, 1% Nonidet P-40, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 1 µg/ml aprotinin, and 1 µg/ml phenylmethylsulfonyl fluoride. Cell lysates were clarified by centrifugation at 10,000 × g for 10 min at 4 °C and normalized for endogenous
Cdc42 levels detected by monoclonal antibody (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA). Affinity purifications were carried out at
4 °C for 1 h, washed three times in an excess of lysis buffer,
and then analyzed by Western blot.
 |
RESULTS |
Functional Analysis of the Exchange Mechanism--
The structures
of Tiam1 (T-cell lymphoma invasion
and metastasis 1), Dbs, and
intersectin in complex with their cognate Rho GTPases (5, 7, 8) suggest
that DH domains catalyze exchange by repositioning the GTPase switch
regions to disorganize the nucleotide binding pocket and directly
occlude the Mg2+ binding site. As we have previously
described (7), the repositioning of Cys18,
Val33, Ala59, and Glu62 (Cdc42
numbering) within the complexes appears essential for efficient guanine
nucleotide exchange (Fig. 1). In order to
better understand the contribution of these four residues to the
exchange reaction, we have assessed the mechanistic effects of
substitutions at these positions within Cdc42 using a combination of
fluorescence spectroscopy to measure guanine nucleotide exchange rates
and surface plasmon resonance to measure affinities of complex
formation.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 1.
Remodeling of Cdc42 switches.
A, switches (red) of Cdc42 are remodeled upon
binding Dbs. Dbs-bound Cdc42 (5) (green; every 10th residue
numbered) is superimposed on Cdc42 (transparent
gray) bound to GDP (coordinates provided by N. Nassar) (transparent magenta) and
Mg2+ (transparent blue). Details of
rearrangements for switches 1 (B) and 2 (C) are
highlighted with arrows, indicating movements within Cdc42
upon binding Dbs (yellow), and dashed
lines, indicating hydrogen bonds. Similar conformations of
switch 2 are recapitulated in Sos1(Cdc25)·Ras (9) (D) and
magnesium-depleted RhoA·GDP (30) (E). The color
scheme is consistent with the earlier
panels.
|
|
Cys18 and Val33 apparently undergo a concerted
rearrangement within the nucleotide binding pocket upon complex
formation, resulting in reorientation of the cysteine side chain
relative to the nucleotide-bound structures of Rho GTPases. In this new
rotamer conformation, Cys18 can no longer hydrogen-bond to
a nucleotide
-phosphate (Fig. 1B), and loss of this
hydrogen bond should reduce the affinity for nucleotide and promote
exchange in the absence of GEF. Consequently, and as expected,
substitution of Cys18 to alanine increases the spontaneous
loading of mant-GTP onto Cdc42 (~0.0044/s versus 0.0003/s
for Cdc42(WT)), partially mimicking the
action of Dbs (Fig. 2A, Table
I). The further stimulation of
Cdc42(C18A) by Dbs (~0.0461/s) undoubtedly arises from GEF-induced alterations to portions of the active site outside the
phosphate-binding loop.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 2.
Kinetic analysis of Cdc42 guanine nucleotide
exchange mechanism mutants. Cdc42 mutants containing substitutions
C18A (A), V33A (B), A59G (C), and E62A
(D) were tested for the ability to be activated by Dbs. For
each mutant, the intrinsic (blue, closed
triangles) and Dbs-catalyzed (red,
closed squares) guanine nucleotide exchange rates
are shown relative to the equivalent exchange reactions
(gray) for Cdc42(WT) (intrinsic (open
triangles) and Dbs-catalyzed (open
squares)). Sensorgrams of Cdc42(WT) (E and
H), Cdc42(C18A) (F and I), and
Cdc42(V33A) (G and J) showing binding to a Dbs
DH/PH domain surface were measured in the presence (E-G)
and absence (H-J) of 50 µM EDTA by surface
plasmon resonance as described under "Experimental Procedures."
Concentrations of Cdc42 proteins used are 0.156 µM
(magenta), 0.313 µM (purple), 0.625 µM (green), 1.25 µM
(gold), and 2.5 µM (red).
RU, response units.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Rate and binding constants for Dbs-catalyzed guanine nucleotide
exchange of wild type and mutant Cdc42 proteins
Rates (kobs) of guanine nucleotide exchange for the
various Cdc42 proteins were determined by fitting the data from Fig. 2
to a single exponential decay function. -Fold stimulation is the
corresponding ratio of rates for the Dbs-catalyzed versus
intrinsic exchange reactions. kobs values are the
mean of at least two experiments with S.D. values.
Kd values are estimated from the SPR data in Fig. 2.
NB, no binding detected.
|
|
Within the GEF·GTPase structures (5, 7, 8), the side chains of
residues analogous to Val33 within Cdc42 are moved into the
site normally occupied by Cys18, promoting an alternate
rotamer conformation of the cysteine residue that can no longer
hydrogen-bond to the
-phosphate of guanine nucleotides (Fig.
1B). Therefore, substitution of Val33 to alanine
within Cdc42 was designed to decouple structural alterations propagating from switch 1 to Cys18 within the phosphate
binding loop. Since the rearrangement of Cys18 is predicted
to be critically important to the GEF-catalyzed exchange reaction,
mutation of Val33 was anticipated to hinder Dbs-catalyzed
guanine nucleotide exchange. Experimentally, Cdc42(V33A) bound to Dbs
with an affinity similar to Cdc42(WT) (Fig. 2, G and
J, Table I). In addition, the Dbs-catalyzed rate of mant-GTP
loading was only mildly impaired on Cdc42(V33A) (Fig. 2B,
Table I). However, this observation is complicated by an ~5-fold
increase in the intrinsic exchange rate within Cdc42(V33A) versus wild type (~0.0015/s versus ~0.0003/s,
respectively), reducing the overall efficiency of Dbs-catalyzed
exchange on Cdc42(V33A) (10-fold versus 72-fold stimulation
for wild type) (Table I). These results are most easily explained by
postulating that Val33 is needed not only to transmit
structural alterations within switch 1 to Cys18 but also to
maintain the overall integrity of the nucleotide binding pocket
irrespective of Dbs engagement.
Within conserved region 1 of the Dbs DH domain, the side chain of
Glu639 is clearly critical for stabilizing switch 1 (Fig.
1B) and hydrogen-bonds with the hydroxyl of
Tyr32 and the backbone nitrogens of Thr35 and
Val36. The equivalent of Glu639 is highly
conserved among DH domains. Consistent with the necessity for Dbs to
rearrange switch 1 of Cdc42 to effect exchange, mutation of the
conserved glutamate (E639A) decreases the rates of Dbs-catalyzed exchange upon Cdc42 and RhoA 29- and 21-fold from wild-type rates, respectively (Fig. 3 and Table
II). Residues analogous to
Glu639 have been previously assessed for their role in
nucleotide exchange for other Dbl family members (4, 22), and
substitutions at these sites are consistently detrimental to catalyzed
exchange, further indicating a conserved mechanism utilized among Dbl
family proteins.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 3.
Dbs(E639A) exchange of Cdc42 and RhoA.
Dbs(E639A) (red lines, open
circles) was tested for its ability to catalyze guanine
nucleotide exchange of 1 µM Cdc42 (A) or RhoA
(B). Also shown are the intrinsic (gray
lines, open triangles) and wild-type
Dbs-catalyzed (gray lines, open
squares) exchange of Cdc42 and RhoA.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Rate constants of guanine nucleotide exchange reactions catalyzed by
wild type and mutant Dbs proteins on Cdc42 and RhoA
Rates (kobs) of guanine nucleotide exchange for wild
type Cdc42 (left) or RhoA (right) stimulated by various Dbs proteins
were determined by fitting the data from Fig. 3 as single exponential
decays. The -fold stimulation for each Dbs protein reflects the ratio
of kobs measured for the GEF-containing reaction to
the unstimulated reaction containing no GEF (none).
|
|
Ala59 of Cdc42 is repositioned upon complex formation with
Dbs to occlude the Mg2+ binding site (Fig. 1C).
Glu62 of Cdc42 supports this rearrangement as well as
helping to preserve the integrity of the P-loop through interaction
with Lys16. Repositioning Ala59
(Ala59 in Rac1, Ala61 in RhoA) and
Glu62 (Glu62 in Rac1, Glu64 in
RhoA) occurs identically in the structures of Tiam1·Rac1, Dbs·Cdc42, and Dbs·RhoA, arguing for the importance of these
altered conformations during nucleotide exchange of Rho GTPases.
Consistent with this structural information, both the A59G and E62A
mutations in Cdc42 are extremely deleterious to guanine nucleotide
exchange (Fig. 2, C and D). Both Cdc42(A59G) and
Cdc42(E62A) are essentially unresponsive to Dbs, and despite the fact
that Glu62 undergoes no change in solvent exposure and the
Ala59 methyl carbon loses only ~10 Å2 upon
complex formation, neither mutant displays measurable binding to Dbs as
indicated by surface plasmon resonance (Table I). Furthermore, it is
interesting to note that both A59G and E62A decrease the intrinsic
rates of exchange for Cdc42, arguing that disruption of
Mg2+ binding is important for spontaneous exchange within
the GTPase.
C18A as a Dominant Negative Mutation--
When a mutation in a
GTPase decreases affinity for bound nucleotide, the GTPase may behave
as a so-called "dominant negative" in the presence of its exchange
factor, displaying increased affinity toward the GEF because it is less
easily displaced through nucleotide binding. Accordingly, Cdc42(C18A)
binds with increased affinity to Dbs both in the presence and absence
of nucleotide (Fig. 2, F and I; Table I).
Consistent with this behavior, Cdc42(C18A) effectively inhibits
Dbs-catalyzed exchange of wild-type Cdc42 in vitro (Fig.
4). Similarly, Cdc42(C18A) inhibits the
ability of Dbl, a close homologue of Dbs, to elicit transcription by
NF-
B normally associated with Cdc42 activation in vivo
(Fig. 5). Transcriptional inhibition by
Cdc42(C18A) and the classical dominant-negative Cdc42(T17N) are roughly
equal, indicating that Cdc42(C18A) is a potent dominant negative of
Cdc42 activity.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Cdc42 (C18A) inhibits Dbs exchange of wild
type GTPase. Inhibition of the Dbs-stimulated exchange of
mant-GDP-loaded Cdc42(WT) by Cdc42(C18A). Reactions contained 200 nM Dbs DH/PH, 400 nM mant-GDP-loaded Cdc42(WT),
20 µM GDP, and a 2 µM concentration of
either Cdc42(WT) (gray) or Cdc42(C18A) (red).
Measured rates (kobs) for each reaction were
0.0055 s 1 for Cdc42 and 0.0029 s 1 for Cdc42(C18A).
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 5.
The Cdc42(C18A) mutant functions as a
dominant inhibitor. A, Dbl-HA1 activates Cdc42 in COS-7
cells. COS-7 cells were transiently transfected with 3 µg of pAX142
( GEF) or pAX142-Dbl-HA1 (+ GEF), along with 3 µg of Cdc42(WT).
Lysates were collected at 48 h and examined by Western blots for
overall expression of Cdc42 and Dbl-HA1 as indicated as well as
activated Cdc42 (GTP-bound) isolated by affinity purification with
GST-PBD. B, Cdc42(C18A) blocks activation of an
NF- B-responsive transcriptional reporter by Dbl-HA1. COS-7 cells
were co-transfected with 3 µg of pAX142 (vector), pAX142-Cdc42(WT),
pAX142-Cdc42(17N), or pAX142-Cdc42(C18A), along with 3 µg of
pAX142-Dbl(HA1), 2.5 µg of NF- B-luc, and 500 ng of
pCMVnlac as an internal control for transfection efficiency and/or
growth inhibition. Luciferase and -galactosidase levels were
measured and expressed as -fold activation relative to the level of
activation seen with empty vector control. Luciferase activity was then
standardized relative to -galactosidase activity. Data shown are
representative of three independent experiments performed on triplicate
plates. Error bars indicate S.D. values.
|
|
 |
DISCUSSION |
In general, Dbl family proteins catalyze exchange without directly
impinging upon the binding sites for either guanine nucleotides or the
magnesium co-factor. Instead, RhoGEFs manipulate GTPase residues to
promote ejection of GDP and Mg2+. The molecular
rearrangements originally seen in Rac1 bound to Tiam1 (7) and
recapitulated in the structures of Dbs·Cdc42 (5), Dbs·RhoA, and
intersectin·Cdc42 (8) strongly support the assumption of a conserved
exchange mechanism for all Dbl family proteins.
Specifically, repositioning of switch 1 of Cdc42 moves
Phe28 away from the nucleotide base, displaces
Thr35 so that it no longer interacts favorably with the
Mg2+ ion, and, via Val33, alters the side chain
conformer of Cys18 so that it can no longer hydrogen-bond
with the
-phosphate of GDP (Fig. 1B). The importance of
Phe28 was highlighted in a previous study (23), where
substitution of this residue to leucine in Cdc42 results in a "fast
cycling" mutant with spontaneous exchange on par with Dbl-catalyzed
exchange. Less well appreciated is the role of Cys18 of
Cdc42 in binding nucleotides. However, the results presented here
clearly demonstrate a critical role for Cys18 of Cdc42 in
binding nucleotides and participating in a conserved exchange reaction
catalyzed by RhoGEFs. With the exception of the three Rnd proteins
(Rho6/Rnd1, Rho7/Rnd2, and Rho8/RhoE/Rnd3) that feature an alanine at
position 18, all other Rho family members possess either a cysteine or
the isosteric serine at this position. When Cys18 is
substituted to alanine, Cdc42 loses the ability to bind nucleotide with
high affinity, resulting in rapid exchange. Similarly, alanine at this
position in the Rnd proteins may underlie their relatively high rates
of spontaneous nucleotide exchange (24).
Like the Rnd proteins, Ras possesses an alanine at position 18 that
cannot hydrogen-bond to the nucleotide
-phosphate. However, Ras,
rather than binding weakly to nucleotides like the Rnd proteins, possesses other subtle differences in its active site and binds nucleotides with higher affinity than the Rho proteins (25, 26).
Nevertheless, Powers et al. (27) have shown that the A25P
mutation in yeast RAS (equivalent to A18P in human H-Ras) conferred a dominant-interfering phenotype. Examination of the nucleotide-bound H-Ras crystal structure (protein data bank code 121P)
reveals that A18P would disrupt protein-nucleotide interactions primarily by introducing steric conflict with a bound nucleotide, unlike C18A in Cdc42, which introduces a smaller side chain and directly abolishes a positive protein-nucleotide interaction.
Furthermore, like Cdc42(C18A), Ras(D119N) has decreased affinity for
nucleotides, resulting in increased affinity of Ras for its exchange
factor, Sos1 (son of sevenless)
(23, 28), with associated pleiotropic effects in vivo. For
instance, at low expression levels, Ras(D119N) produces a dominant
negative phenotype presumably by sequestering Sos1. However, at
expression levels much higher than endogenous GEFs, Ras(D119N) is
largely unbound by GEFs and overly active, since the mutation does not
compromise effector binding and GTP is rapidly loading. Cdc42(C18A) may
behave similarly, and more extensive analyses are necessary to fully
understand the consequences of Cdc42(C18A) expression in
vivo.
Finally, a naturally occurring mutation within Ras, A18T, occurs at the
analogous position to Cys18 in Cdc42 and is associated with
excellent prognosis for patients with malignant melanoma (29). Like
Cdc42(C18A), Ras(A18T) also increases spontaneous nucleotide exchange
rates, and we suggest that Ras(A18T) may inhibit Ras functions and
associated tumor progression by sequestering GEFs.
The importance of stabilizing the conserved conformational alterations
of switch 1 by RhoGEFs is further emphasized by the role of
Glu639 of Dbs (Fig. 1B). This residue makes
three conserved hydrogen bonds to switch 1 of Cdc42 that are crucial
for reconfiguring switch 1 to promote nucleotide ejection. Not
surprisingly, when Glu639 is substituted with alanine
(E639A), Dbs only weakly catalyzes the exchange of nucleotides within
Cdc42 or RhoA.
Dbl family proteins stabilize nearly identical conformations of switch
2 in Rho GTPases, and these conformations are similarly recapitulated
in the structures of Ras (Fig. 1D) or Ran in complex with
their exchange factors (9, 10) as well as the structure of RhoA bound
to GDP but without magnesium (Fig. 1E) (30). This latter
structure is particularly intriguing, since it may represent a stable
intermediate along the reaction coordinate for exchange that is
subsequently bound by GEFs (30). In light of this idea, the failure of
Cdc42(E62A) to bind Dbs might be explained best as a recognition
problem; i.e. Cdc42(E62A) is either never adopting the
correct conformation of switch 2 conducive to Dbs-catalyzed exchange,
or the sampling of this conformation is too short lived for productive
engagement of Dbs. In favor of the idea that certain dynamic states of
the switch regions promote binding in native GTPases, Spoerner et
al. (31) have shown that mutation of Thr35 to serine
in Ras dramatically alters the dynamic equilibrium of the effector loop
to favor conformations incompetent for effector binding.
Although the side chain of Ala59 of Cdc42 does make minimal
contact with Dbs, similar to the other RhoGEF·GTPase structures, the
primary interaction is through its carbonyl oxygen, which interacts
with a conserved positively charged side chain within the DH domain
(Lys774 in Dbs; Lys1195 in Tiam1;
Arg1384 via a water molecule in intersectin) (Fig.
1C). In theory, this interaction should be preserved in the
A59G mutation. Nevertheless, Cdc42(A59G) has a greatly reduced affinity
for Dbs under the surface plasmon resonance assay
conditions. This reduction in binding may arise from the introduction
of conformational freedom within switch 2, (similar to that postulated
for Cdc42(E62A)), or the Ala59 side chain may be
instrumental in the transient removal of Mg2+ in the
absence of GEF. Since both the A59G and E62A substitutions significantly reduced the intrinsic rate of exchange of Cdc42, this
latter explanation is an attractive possibility for either mutant.
Generally, mutations similar to E62A of Cdc42 in other GTPases
(Ran(E70A), Ras(E62H)) also severely impair GEF-catalyzed nucleotide exchange (10, 32), suggesting that identical aspects of GEF-catalyzed exchange are conserved among different GTPase families. However, on a
cautionary note, Ala59 of Ras bound to Sos (9) occupies the
same position as Ala59 of Cdc42 bound to Dbs (Fig. 1,
C and D), yet A59G in Ras has no effect on the
rate of GDP release catalyzed by Sos (33). Therefore, the GEF-catalyzed
exchange reactions for Ras and Rho GTPases do not appear identical
despite significant structural similarities.
Recently, the structure of the bacterial RhoGEF, SopE, has been
determined in complex with nucleotide- and Mg2+-free Cdc42
(11). Interestingly, although SopE is specific for Cdc42 and Rac1 (34),
the overall architecture of SopE is unrelated to DH domains. However,
superpositioning of SopE-bound Cdc42 with Dbs-bound Cdc42 reveals that
switches 1 and 2 of the GTPase are in nearly identical conformations
when complexed to either GEF. In addition, key GEF/GTPase interactions
with the switch regions have been preserved, with SopE featuring
Asp124 stabilizing switch 1 (equivalent to
Glu639 in Dbs) and Gln109 (equivalent to
Asn810 in Dbs) involved in binding switch 2 (5, 11). Within
SopE·Cdc42, Cys18, Val33, Ala59,
and Glu62 are reoriented to nearly identical positions
relative to Dbs·Cdc42, and these residues are presumably similarly
involved in nucleotide exchange. Overall, these structural similarities
suggest that SopE catalyzes guanine nucleotide exchange of Rho
GTPases similar to Dbl family proteins.
 |
ACKNOWLEDGEMENTS |
We are grateful to M. Pham and S. Gershburg
for technical assistance and N. Nassar for providing unpublished
coordinates of Cdc42·GDP·Mg2+.
 |
FOOTNOTES |
*
This work was supported in part by American Cancer Society
Fellowship PF-00-163-01-GMC (to D. K. W.) and National Institutes of
Health Grants R01-GM62299 (to J. S.) and CA-77493 (to I. P. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
These authors contributed equally to this work.

To whom correspondence should be addressed: Dept. of
Pharmacology, University of North Carolina, CB #7365, 1106 M. E. J. Bldg., Chapel Hill, NC 27599. Tel.: 919-966-7530; Fax:
919-966-5640; E-mail: sondek@med.unc.edu.
Published, JBC Papers in Press, October 24, 2002, DOI 10.1074/jbc.M208580200
 |
ABBREVIATIONS |
The abbreviations used are:
GAP, GTPase-activating protein;
GEF, guanine nucleotide exchange
factor;
DH, Dbl homology;
PH, pleckstrin homology;
WT, wild type;
RU, response units;
GST, glutathione
S-transferase;
PBD, p21 binding domain;
mant, N-methylanthraniloyl..
 |
REFERENCES |
| 1.
|
Whitehead, I. P.,
Campbell, S.,
Rossman, K. L.,
and Der, C. J.
(1997)
Biochim. Biophys. Acta
1332,
F1-F23[Medline]
[Order article via Infotrieve]
|
| 2.
|
Zheng, Y.
(2001)
Trends Biochem. Sci.
26,
724-732[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Hoffman, G. R.,
and Cerione, R. A.
(2002)
FEBS Lett.
513,
85-91[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Liu, X.,
Wang, H.,
Eberstadt, M.,
Schnuchel, A.,
Olejniczak, E. T.,
Meadows, R. P.,
Schkeryantz, J. M.,
Janowick, D. A.,
Harlan, J. E.,
Harris, E. A.,
Staunton, D. E.,
and Fesik, S. W.
(1998)
Cell
95,
269-277[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Rossman, K. L.,
Worthylake, D. K.,
Snyder, J. T.,
Siderovski, D. P.,
Campbell, S. L.,
and Sondek, J.
(2002)
EMBO J.
21,
1315-1326[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Cherfils, J.,
and Chardin, P.
(1999)
Trends Biochem. Sci.
24,
306-311[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Worthylake, D. K.,
Rossman, K. L.,
and Sondek, J.
(2000)
Nature
408,
682-688[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Snyder, J. T.,
Worthylake, D. K.,
Rossman, K. L.,
Betts, L.,
Pruitt, W. M.,
Siderovski, D. P.,
Der, C. J.,
and Sondek, J.
(2002)
Nat. Struct. Biol.
9,
468-475[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Boriack-Sjodin, P. A.,
Margarit, S. M.,
Bar-Sagi, D.,
and Kuriyan, J.
(1998)
Nature
394,
337-343[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Renault, L.,
Kuhlmann, J.,
Henkel, A.,
and Wittinghofer, A.
(2001)
Cell
105,
245-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Buchwald, G.,
Friebel, A.,
Galan, J. E.,
Hardt, W. D.,
Wittinghofer, A.,
and Scheffzek, K.
(2002)
EMBO J.
21,
3286-3295[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Leonard, D. A.,
Evans, T.,
Hart, M.,
Cerione, R. A.,
and Manor, D.
(1994)
Biochemistry
33,
12323-12328[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Klebe, C.,
Nishimoto, T.,
and Wittinghofer, F.
(1993)
Biochemistry
32,
11923-11928[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Klebe, C.,
Bischoff, F. R.,
Ponstingl, H.,
and Wittinghofer, A.
(1995)
Biochemistry
34,
639-647[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Whitehead, I. P.,
Kirk, H.,
and Kay, R.
(1995)
Oncogene
10,
713-721[Medline]
[Order article via Infotrieve]
|
| 16.
|
Whitehead, I. P.,
Lambert, Q. T.,
Glaven, J. A.,
Abe, K.,
Rossman, K. L.,
Mahon, G. M.,
Trzaskos, J. M.,
Kay, R.,
Campbell, S. L.,
and Der, C. J.
(1999)
Mol. Cell. Biol.
19,
7759-7770[Abstract/Free Full Text]
|
| 17.
|
Glaven, J. A.,
Whitehead, I.,
Bagrodia, S.,
Kay, R.,
and Cerione, R. A.
(1999)
J. Biol. Chem.
274,
2279-2285[Abstract/Free Full Text]
|
| 18.
|
Westwick, J. K.,
Lambert, Q. T.,
Clark, G. J.,
Symons, M.,
Van Aelst, L.,
Pestell, R. G.,
and Der, C. J.
(1997)
Mol. Cell. Biol.
17,
1324-1335[Abstract]
|
| 19.
|
Hauser, C. A.,
Westwick, J. K.,
and Quilliam, L. A.
(1995)
Methods Enzymol.
255,
412-426[Medline]
[Order article via Infotrieve]
|
| 20.
|
Quilliam, L. A.,
Khosravi-Far, R.,
Huff, S. Y.,
and Der, C. J.
(1995)
Bioessays
17,
395-404[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Korus, M.,
Mahon, G. M.,
Cheng, L.,
and Whitehead, I. P.
(2002)
Oncogene
21,
4601-4612[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Aghazadeh, B.,
Zhu, K.,
Kubiseski, T. J.,
Liu, G. A.,
Pawson, T.,
Zheng, Y.,
and Rosen, M. K.
(1998)
Nat. Struct. Biol.
5,
1098-1107[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Lin, R.,
Bagrodia, S.,
Cerione, R.,
and Manor, D.
(1997)
Curr. Biol.
7,
794-797[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Nobes, C. D.,
Lauritzen, I.,
Mattei, M. G.,
Paris, S.,
Hall, A.,
and Chardin, P.
(1998)
J. Cell Biol.
141,
187-197[Abstract/Free Full Text]
|
| 25.
|
Ihara, K.,
Muraguchi, S.,
Kato, M.,
Shimizu, T.,
Shirakawa, M.,
Kuroda, S.,
Kaibuchi, K.,
and Hakoshima, T.
(1998)
J. Biol. Chem.
273,
9656-9666[Abstract/Free Full Text]
|
| 26.
|
Zhang, B.,
Zhang, Y.,
Wang, Z.,
and Zheng, Y.
(2000)
J. Biol. Chem.
275,
25299-25307[Abstract/Free Full Text]
|
| 27.
|
Powers, S.,
O'Neill, K.,
and Wigler, M.
(1989)
Mol. Cell. Biol.
9,
390-395[Abstract/Free Full Text]
|
| 28.
|
Cool, R. H.,
Schmidt, G.,
Lenzen, C. U.,
Prinz, H.,
Vogt, D.,
and Wittinghofer, A.
(1999)
Mol. Cell. Biol.
19,
6297-6305[Abstract/Free Full Text]
|
| 29.
|
Demunter, A.,
Ahmadian, M. R.,
Libbrecht, L.,
Stas, M.,
Baens, M.,
Scheffzek, K.,
Degreef, H., De,
Wolf-Peeters, C.,
and van Den Oord, J. J.
(2001)
Cancer Res.
61,
4916-4922[Abstract/Free Full Text]
|
| 30.
|
Shimizu, T.,
Ihara, K.,
Maesaki, R.,
Kuroda, S.,
Kaibuchi, K.,
and Hakoshima, T.
(2000)
J. Biol. Chem.
275,
18311-18317[Abstract/Free Full Text]
|
| 31.
|
Spoerner, M.,
Herrmann, C.,
Vetter, I. R.,
Kalbitzer, H. R.,
and Wittinghofer, A.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
4944-4949[Abstract/Free Full Text]
|
| 32.
|
Mistou, M. Y.,
Jacquet, E.,
Poullet, P.,
Rensland, H.,
Gideon, P.,
Schlichting, I.,
Wittinghofer, A.,
and Parmeggiani, A.
(1992)
EMBO J.
11,
2391-2397[Medline]
[Order article via Infotrieve]
|
| 33.
|
Hall, B. E.,
Yang, S. S.,
Boriack-Sjodin, P. A.,
Kuriyan, J.,
and Bar-Sagi, D.
(2001)
J. Biol. Chem.
276,
27629-27637[Abstract/Free Full Text]
|
| 34.
|
Friebel, A.,
Ilchmann, H.,
Aepfelbacher, M.,
Ehrbar, K.,
Machleidt, W.,
and Hardt, W. D.
(2001)
J. Biol. Chem.
276,
34035-34040[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Hirota, P. Helli, and L. J. Janssen
Ionic mechanisms and Ca2+ handling in airway smooth muscle
Eur. Respir. J.,
July 1, 2007;
30(1):
114 - 133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Oleksy, L/u. Opalinski, U. Derewenda, Z. S. Derewenda, and J. Otlewski
The Molecular Basis of RhoA Specificity in the Guanine Nucleotide Exchange Factor PDZ-RhoGEF
J. Biol. Chem.,
October 27, 2006;
281(43):
32891 - 32897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Barale, D. McCusker, and R. A. Arkowitz
Cdc42p GDP/GTP Cycling Is Necessary for Efficient Cell Fusion during Yeast Mating
Mol. Biol. Cell,
June 1, 2006;
17(6):
2824 - 2838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Schlumberger, A. Friebel, G. Buchwald, K. Scheffzek, A. Wittinghofer, and W.-D. Hardt
Amino Acids of the Bacterial Toxin SopE Involved in G Nucleotide Exchange on Cdc42
J. Biol. Chem.,
July 11, 2003;
278(29):
27149 - 27159.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.